Charles Schwab
TERN

Charles Schwab’s Terns Pharmaceuticals TERN Stock Holding History

Charles Schwab’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.4M Buy
747,377
+10,217
+1% +$420K 0.01% 1306
2025
Q4 		$29.8M Buy
737,160
+153,892
+26% +$3.56M ﹤0.01% 1496
2025
Q3 		$4.38M Buy
583,268
+359,048
+160% +$2.29M ﹤0.01% 2497
2025
Q2 		$836K Buy
224,220
+17,770
+9% +$55.5K ﹤0.01% 2955
2025
Q1 		$570K Hold
206,450
– – ﹤0.01% 3034
2024
Q4 		$1.14M Buy
206,450
+51,736
+33% +$350K ﹤0.01% 2867
2024
Q3 		$1.29M Buy
154,714
+1,994
+1% +$16.4K ﹤0.01% 2839
2024
Q2 		$1.04M Buy
152,720
+38,111
+33% +$231K ﹤0.01% 2919
2024
Q1 		$752K Hold
114,609
– – ﹤0.01% 2882
2023
Q4 		$744K Hold
114,609
– – ﹤0.01% 2929
2023
Q3 		$576K Hold
114,609
– – ﹤0.01% 2993
2023
Q2 		$1M Buy
114,609
+100,898
+736% +$1.18M ﹤0.01% 2764
2023
Q1 		$162K Buy
+13,711
New +$131K ﹤0.01% 3191
2022
Q4 		– Sell
-12,408
Closed -$74K – 3564
2022
Q3 		$74K Buy
+12,408
New +$46.1K ﹤0.01% 3250
2022
Q2 		– Sell
-28,746
Closed -$86K – 3639
2022
Q1 		$86K Hold
28,746
– – ﹤0.01% 3440
2021
Q4 		$204K Sell
28,746
-2,797
-9% -$23.3K ﹤0.01% 3357
2021
Q3 		$329K Buy
31,543
+10,184
+48% +$106K ﹤0.01% 3245
2021
Q2 		$262K Hold
21,359
– – ﹤0.01% 3254
2021
Q1 		$470K Buy
+21,359
New +$468K ﹤0.01% 3102

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Charles Schwab's TERN Position: Q1 2026 in Review

Charles Schwab increased its Terns Pharmaceuticals (TERN) stake by 1.4% in Q1 2026, buying an estimated $420K and bringing the position to 747,377 shares worth $39.4M. The position accounts for 0.01% of the portfolio, ranked #1306.

Charles Schwab first reported a position in TERN in Q1 2021 and has held it in 19 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Charles Schwab held 747,377 shares of Terns Pharmaceuticals worth $39.4M as of Q1 2026.
  • Charles Schwab bought 10,217 Terns Pharmaceuticals shares in Q1 2026, an estimated $420K.
  • Terns Pharmaceuticals made up 0.01% of Charles Schwab's portfolio in Q1 2026, its #1306 holding.
  • Charles Schwab first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.